Abstract
Immunodeficiency disorders have provided much information on the development and interaction of the various B and T lymphoid components in the immune system of man. As the lymphoid system becomes increasingly divided into functional subsets of cells it will be important to find immunodeficiencies affecting newly discovered cell types. Natural killer (NK) cells are a recently described but ill-defined subpopulation of lymphocytes which is thought to play an important part in surveillance against tumour development1. Mice homozygous for the beige gene were found to have a selective deficiency in NK function2 and were more susceptible to transplantation of syngeneic tumours as predicted3,26. We report here that patients carrying the analogous, autosomal recessive Chediak-Higashi (CH) gene have a profound defect in their ability to spontaneously lyse various tumour cells in vitro by either antibody-dependent or independent mechanisms. Since other cell-mediated cytolytic functions were relatively normal, these results suggest that the beige or Chediak-Higashi gene in both man and mouse controls NK function.
Similar content being viewed by others
References
Kiessling, R. & Wigzell, H. Immun. Rev. 44, 165 (1979).
Roder, J. C. & Duwe, A. K. Nature 278, 451 (1979).
Karre, K., Kiessling, R., Klein, G. & Roder, J. Nature (in the press).
Windhorst, D. B. & Padgett, G. J. invest. Derm. 60, 529 (1973).
Page, A. R., Berendes, H., Warner, J. & Good, R. A. Blood 20, 330 (1962).
Vassalli, J. D., Cranelli-Piperno, A., Griscelli, C. & Reich, E. J. exp. Med. 147, 1285 (1978).
Dent, P. B., Fish, L. A., White, J. F. & Good, R. A. Lab. Invest. 15, 1634 (1966).
Gallin, J. I. et al. Blood 53, 226 (1969).
Root, R. K., Rosenthal, A. S. & Balestra, D. J. J. clin. Invest. 51, 649 (1972).
Blume, R. S. & Wolff, S. M. Medicine 51, 247 (1972).
Jondal, M. & Pross, H. Int. J. Cancer 15, 596 (1975).
Roder, J. C., Kiessling, R., Biberfeld, P. & Andersson, B. J. Immun. 121, 2509 (1978).
Roder, J. C., Ahrlund-Richter, L. & Jondal, M. J. exp. Med. 150, 471 (1979).
Cudkowicz, G. & Hochman, P. S. Immun. Rev. 44, 13 (1979).
Roder, J. C. & Klein, M. J. Immun. 123, 2785 (1979).
Oliver, J. & Zurier, R. B. J. clin. Invest. 57, 1239 (1976).
Boxer, L. A. et al. N. Engl. J. Med. 295, 1041 (1976).
Tovey, M. G., Rochette-Egly, C. & Castagna, M. Proc. natn. Acad. Sci. U.S.A. 76, 3890 (1979).
Pross, H., Gupta, S., Good, R. A. & Baines, M. G. Cell Immun. 43, 160 (1979).
Koren, H., Amos, B. & Buckley, R. J. Immun. 120, 796 (1978).
Herberman, R. B. et al. Immun. Rev. 44, 43 (1979).
Ackerman, S. K. & Douglas, S. D. J. Immun. 120, 1372 (1978).
Korec, S., Herberman, R. B., Dean, J. H. & Cannon, G. B. Int. J. Cancer (in the press).
Ortaldo, J. R., Bonnard, G. B., Kind, P. & Herberman, R. B. J. Immun. 122, 1489 (1979).
Alexander, E. & Henkart, P. J. exp. Med. 143, 329 (1976).
Talmadge, J. E., Meyers, K. M., Prieur, D. & Starkey, J. R. Nature (in the press).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roder, J., Haliotis, T., Klein, M. et al. A new immunodeficiency disorder in humans involving NK cells. Nature 284, 553–555 (1980). https://doi.org/10.1038/284553a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/284553a0
- Springer Nature Limited
This article is cited by
-
Targeting natural killer cells in solid tumors
Cellular & Molecular Immunology (2019)
-
Genome-wide screening of mouse knockouts reveals novel genes required for normal integumentary and oculocutaneous structure and function
Scientific Reports (2019)
-
Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy
Experimental & Molecular Medicine (2017)
-
NK cells and cancer: you can teach innate cells new tricks
Nature Reviews Cancer (2016)
-
The Dysfunction of NK Cells in Patients with Type 2 Diabetes and Colon Cancer
Archivum Immunologiae et Therapiae Experimentalis (2013)